"Prime Boost" Vaccination Strategy Combining Conjugated Anti- Pneumococcal Vaccine (s0) and Polysaccharide Anti- Pneumococcal Vaccine (s4) Compared to Polysaccharide Anti- Pneumococcal Vaccine Alone (s4) In Patients With Common Variable Immunodeficiency

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2011
The main objective of this study is to evaluate and to compare the specific antibody response to a \" prime-boost \" vaccine strategy combining the seven valence pneumococcal conjugate vaccine (PnCj) prime at W0 followed by the administration of the pneumococcal capsular polysaccharide vaccine (PPS) boost at W4, to the administration of the pneumococcal capsular polysaccharide vaccine (PPS) alone at W4 in patients with common variable immunodeficiency.
Epistemonikos ID: 2d143ec505c36715121ba0bada6d334790727a97
First added on: Feb 06, 2024